Belgian patent attorney, Dutch patent attorney, European patent attorney
Agrifood, Biochemistry, Biotechnology, Chemical Technology, Gene therapy, Immunology, Immunotherapy, Medical technology, Microbiology, Virology
Before he started working at Arnold & Siedsma, Nick was employed as a consultant at a grants consultancy firm where he provided advice and assistance to companies who applied for (national and European) tax and grant schemes for technological innovation projects. A crucial element in that respect is intellectual property protection.
After his Biotechnology studies at Wageningen University, Nick subsequently obtained his doctorate from Amsterdam University with a thesis on the development of gene therapy to combat HIV-1 based on RNA interference. He carried out his doctoral research at Amsterdam Medical Centre. During this period he gained ample research experience in the field of new antiviral strategies and therapeutic small molecules such as antivirals, small RNAs, vaccines, synthesised albumin, antibodies and biomarkers. His affinity with intellectual property grew during this period, where the promotional research was a follow-up of two patent applications.
Analytical, inquisitive, result driven, a go-getter and disciplined